Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral immunoglobulins for gastroenteritis

S J Dattani1, J F Connelly

  • 1University of North Carolina at Chapel Hill Drug Information Center, North Carolina Baptist Hospitals, Winston-Salem, USA.

The Annals of Pharmacotherapy
|November 1, 1996
PubMed
Summary

Oral immunoglobulin therapy shows promise for severe gastrointestinal infections, but further research is needed. Optimal treatment parameters and patient selection require larger clinical trials to confirm efficacy and cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperammonaemia due to ornithine transcarbamylase deficiency.

Archives of disease in childhood·2010
Same author

Suxamethonium-induced hyperkalaemia 6 weeks after chemoradiotherapy in a patient with rectal carcinoma.

British journal of anaesthesia·2007
Same author

Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 1: The screening programme, demography, baseline perinatal data and diagnostic classification.

Journal of pediatric endocrinology & metabolism : JPEM·2002
Same author

Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 2: Treatment, progress and outcome.

Journal of pediatric endocrinology & metabolism : JPEM·2002
Same author

Publication rates of abstracts from two pharmacy meetings.

The Annals of pharmacotherapy·2000
Same author

Distribution plan for immune globulin intravenous during a shortage.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999

Area of Science:

  • Gastroenterology
  • Immunology
  • Pediatrics

Background:

  • Preliminary evidence suggests oral immunoglobulin therapy may benefit severe gastrointestinal (GI) infections.
  • Current data primarily derives from case series and small, uncontrolled trials, limiting definitive conclusions.
  • Lack of standardized patient selection criteria hinders therapeutic application.

Purpose of the Study:

  • To review the current literature on oral immunoglobulin therapy for GI infections.
  • To identify gaps in knowledge regarding optimal treatment protocols and patient selection.
  • To assess the potential cost-effectiveness of this therapy in pediatric gastroenteritis.

Main Methods:

  • Literature review of existing studies on oral immunoglobulin therapy in GI infections.
  • Analysis of available data on antibody class, dosage, and treatment duration.
  • Evaluation of patient populations and selection criteria in reported cases.

Main Results:

  • Optimal antibody class, dosage, and duration for oral immunoglobulin therapy remain undefined.
  • Larger, controlled clinical trials are necessary to establish efficacy and safety.
  • Cost-benefit analysis suggests limited justification for widespread use in pediatric gastroenteritis.

Conclusions:

  • Oral immunoglobulin therapy shows potential for severe GI infections but requires further rigorous investigation.
  • Defining optimal treatment parameters and patient selection criteria is crucial for future clinical application.
  • The high cost may limit the clinical utility of this therapy, particularly in pediatric populations.

Related Experiment Videos